RCRajshekhar Chakraborty

Rajshekhar Chakraborty

*This is an algorithmically generated author record based on publicly available information.

Rajshekhar Chakraborty has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Shiva Kumar Reddy Mukkamalla

    Department of Internal Medicine, Queens Hospital Center (Affiliated Icahn School of Medicine at Mount Sinai), Jamaica, NY, USA

    2 shared publications
  • Areej R. El-Jawahri

    Division of Hematology/Oncology,Massachusetts General Hospital,Boston,Massachusetts

    1 shared publication
  • Aric D. Parnes

    Department of Medicine,Brigham and Women's Hospital,Harvard Medical School,Boston,Massachusetts

    1 shared publication
  • Bipin N. Savani

    Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee

    1 shared publication
  • Garfield Gutzmore

    Department of Internal Medicine, Queens Hospital Center (Affiliated Icahn School of Medicine at Mount Sinai), Jamaica, NY, USA

    1 shared publication
  • Hon Cheung Chan

    Department of Internal Medicine, Queens Hospital Center (Affiliated Icahn School of Medicine at Mount Sinai), Jamaica, NY, USA

    1 shared publication

Latest Publications

  • Top Cited Papers

    A systematic review of religious beliefs about major end-of-life issues in the five major world religions

    by Rajshekhar Chakraborty, Areej R. El-Jawahri, Mark R. Litzow, Karen L Syrjala, Aric D. Parnes, Shahrukh K. Hashmi

    Objective: The objective of this study was to examine the religious/spiritual beliefs of followers of the five major world religions about frequently encountered medical situations at the end of life (EoL).Method: This was a systematic review of observational studies on the religious aspects of commonly encountered EoL situations. The databases used for retrieving studies were: Ovid MEDLINE In-Process & Other Non-Indexed Citations, Ovid MEDLINE, Ovid EMBASE, Ovid PsycINFO, Ovid Cochrane Central Register of Controlled Trials, Ovid Cochrane Database of Systematic Reviews, and Scopus. Observational studies, including surveys from healthcare providers or the general population, and case studies were included for review. Articles written from a purely theoretical or philosophical perspective were excluded.Results: Our search strategy generated 968 references, 40 of which were included for review, while 5 studies were added from reference lists. Whenever possible, we organized the results into five categories that would be clinically meaningful for palliative care practices at the EoL: advanced directives, euthanasia and physician-assisted suicide, physical requirements (artificial nutrition, hydration, and pain management), autopsy practices, and other EoL religious considerations. A wide degree of heterogeneity was observed within religions, depending on the country of origin, level of education, and degree of intrinsic religiosity.Significance of results: Our review describes the religious practices pertaining to major EoL issues and explains the variations in EoL decision making by clinicians and patients based on their religious teachings and beliefs. Prospective studies with validated tools for religiosity should be performed in the future to assess the impact of religion on EoL care.


  • Open Access

    A perspective on complementary/alternative medicine use among survivors of hematopoietic stem cell transplant: Benefits and uncertainties

    by Rajshekhar Chakraborty, Bipin N. Savani, Mark Litzow, Mohamad Mohty, Shahrukh Hashmi

    The widespread use of complementary and alternative medicine (CAM) in cancer survivors is well known despite a paucity of scientific evidence to support its use. The number of survivors of hematopoietic stem cell transplant (HCT) is growing rapidly and HCT clinicians are aware that many of their patients use CAM therapies consistently. However, due to a paucity of data regarding the benefits and harms of CAM therapies in these survivors, clinicians are reluctant to provide specific recommendations for or against particular CAM therapies. A systematic literature review was conducted with a search using PubMed, the Cochrane Database of Systematic Reviews, and Ovid online for each CAM therapy as defined by the National Center of Complementary and Alternative Medicine. The search generated 462 references, of which 26 articles were deemed to be relevant for the review. Due to extensive heterogeneity in data and limited randomized trials, a meta‐analysis could not be performed but a comprehensive systematic review was conducted with specified outcomes for each CAM therapy. In randomized controlled trials, certain mind and body interventions such as relaxation were observed to be effective in alleviating psychological symptoms in patients undergoing HCT, whereas the majority of the other CAM treatments were found to have mixed results. CAM use is an understudied area in HCT survivorship and clinicians should convey the benefits and uncertainties concerning the role of CAM therapies to their patients. Cancer 2015;121:2303–2313. © 2015 American Cancer Society.


  • Open Access

    A case of Hodgkin’s lymphoma with severely impaired liver function treated successfully with gemcitabine followed by ABVD

    by Rajshekhar Chakraborty, Shiva Kumar Reddy Mukkamalla, Garfield Gutzmore, Hon Cheung Chan

    Hodgkin’s lymphoma (HL) originates from clonal B cells and is the most common malignancy in the second decade of life. Liver involvement is uncommon at presentation in patients with HL and there is a paucity of data for treatment of patients with severely impaired liver function. We present an unusual case of HL with severe hepatic impairment, splenomegaly and multiple chromosomal abnormalities that was treated initially with gemcitabine and steroids. Once liver function tests improved, six cycles of Adriamycin, bleomycin, vinblastine, and dacarbazine were administered. The patient remains in remission at 3.5 years of follow-up.